Tocilizumab for COVID-19: a real 'miracle drug'?
作者信息
Nasim Sundus, Hashmi Shariq Haider, Azim Dua, Kumar Sohail, Nasim Jasia
机构信息
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
NYU Grossman School of Medicine, New York City, NY, USA.
出版信息
Infect Dis (Lond). 2020 Sep;52(9):681-682. doi: 10.1080/23744235.2020.1780307. Epub 2020 Jun 17.
Abstract
摘要
相似文献
1
Tocilizumab for COVID-19: a real 'miracle drug'?
Infect Dis (Lond). 2020 Sep;52(9):681-682. doi: 10.1080/23744235.2020.1780307. Epub 2020 Jun 17.
2
Tocilizumab in COVID-19: Beware the risk of intestinal perforation.
Int J Antimicrob Agents. 2020 Jul;56(1):106009. doi: 10.1016/j.ijantimicag.2020.106009. Epub 2020 May 7.
3
Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome.
Am J Hematol. 2020 Aug;95(8):E192-E194. doi: 10.1002/ajh.25855. Epub 2020 May 16.
4
First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19.
Chest. 2020 Nov;158(5):2233. doi: 10.1016/j.chest.2020.06.052.
5
Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
Kidney Int. 2020 Oct;98(4):1054. doi: 10.1016/j.kint.2020.06.025. Epub 2020 Jul 8.
6
Early tocilizumab treatment could improve survival among COVID-19 patients.
Clin Exp Rheumatol. 2020 May-Jun;38(3):578. Epub 2020 May 27.
7
Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
Ann Intern Med. 2020 Sep 15;173(6):501-503. doi: 10.7326/L20-0419. Epub 2020 May 18.
8
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
Ann Rheum Dis. 2020 May;79(5):668-669. doi: 10.1136/annrheumdis-2020-217442. Epub 2020 Apr 2.
9
Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.
10
Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.
Br J Haematol. 2020 Jul;190(1):e9-e11. doi: 10.1111/bjh.16787. Epub 2020 May 18.
引用本文的文献
1
Progress on diagnosis and treatment of multisystem inflammatory syndrome in children.
Front Immunol. 2025 Feb 19;16:1551122. doi: 10.3389/fimmu.2025.1551122. eCollection 2025.
Zotero 插件